Produktname:N-[3-[[3-(3,5-dimethoxyanilino)quinoxalin-2-yl]sulfamoyl]phenyl]-3-methoxy-4-methylbenzamide
IUPAC Name:N-[3-({3-[(3,5-dimethoxyphenyl)amino]quinoxalin-2-yl}sulfamoyl)phenyl]-3-methoxy-4-methylbenzamide
- CAS:934529-30-3
- Molekulare Formel:C31H29N5O6S
- Reinheit:95%+
- Katalognummer:CM758151
- Molekulargewicht:599.66
Packungseinheit |
Verfügbarer Vorrat |
Preis($) |
Menge |
Nur für den Einsatz in Forschung und Entwicklung..
Produkt-Details
- CAS-Nr.:934529-30-3
- Molekulare Formel:C31H29N5O6S
- Schmelzpunkt:-
- SMILES-Code:COC1=CC(OC)=CC(NC2=C(NS(=O)(=O)C3=CC=CC(NC(=O)C4=CC(OC)=C(C)C=C4)=C3)N=C3C=CC=CC3=N2)=C1
- Dichte:
- Katalognummer:CM758151
- Molekulargewicht:599.66
- Siedepunkt:
- Mdl-Nr.:MFCD22123237
- Lagerung:
Category Infos
- Quinoxalines
- Quinoxalines, also known as benzopyrazines, are heterocyclic compounds containing a ring complex consisting of a benzene ring and a pyrazine ring. It has isomerism with other naphthalene compounds such as quinazoline, phthalazine, cinnamine, etc. Fusion N-heterocyclic compounds are widely used as valuable entities for the expansion of important pharmacological agents and are considered to be an advantageous scaffold material. Among the numerous fused N-heterocyclic compounds, cinnoline, quinoxaline and quinazoline are important pharmacological agents. In medicinal chemistry, these N-heterocyclic compounds have a wide range of biological properties and can be used as synthetic intermediates, potential drug candidates and chemical probes.